Development of safe and effective bacteriophage-mediated therapies against C. difficile infections – a proof-of-concept preclinical study

author
statement of authorship
Torben Sølbeck Rasmussen, Sarah Forster, Sabina Birgitte Larsen, Alexandra Von Münchow, Kaare Dyekær Tranæs, Anders Brunse, Josue Leonardo Castro Mejia, Signe Adamberg, Axel Kornerup Hansen, Kaarel Adamberg, Camilla Hartmann Friis Hansen, Dennis Sandris Nielsen
source
publisher
year of publication
pages
28 p. : ill
subject term
ISSN
2692-8205
Open Access
Open Access (roheline)
classifier
6.7
language
inglise
Rasmussen, T.S., Forster S., Larsen, S.B., Münchow A. von, Tranæs, K.D., Brunse, A.,Castro Mejia, J.L., Adamberg, S., Hansen, A.K., Adamberg, K. et al Development of safe and effective bacteriophage-mediated therapies against C. difficile infections – a proof-of-concept preclinical study // bioRxiv (2023), 28 p. : ill. https://doi.org/10.1101/2023.03.17.532897 https://www.biorxiv.org/content/biorxiv/early/2023/03/17/2023.03.17.532897.full.pdf